Flicker, L; Grimley Evans, G (2001). «Piracetam for dementia or cognitive impairment.». The Cochrane Database of Systematic Reviews (2): CD001011. doi:10.1002/14651858.CD001011. PMID11405971.
«Pharmacotherapy for Vascular Cognitive Impairment». CNS Drugs31 (9): 759–776. September 2017. doi:10.1007/s40263-017-0459-3. PMID28786085. «Other medications have been considered or tried for the treatment of VCI or VaD. These include [...] piracetam. There is no convincing evidence about the efficacy of these medications in the treatment of VCI.».
«Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders». Drugs70 (3): 287–312. February 2010. doi:10.2165/11319230-000000000-00000. PMID20166767.
«Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials». CNS Drugs30 (7): 575–87. July 2016. doi:10.1007/s40263-016-0348-1. PMID27236454.
«Effects of Central Nervous System Drugs on Recovery After Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials». Clinical Drug Investigation37 (10): 901–928. October 2017. doi:10.1007/s40261-017-0558-4. PMID28756557.
«Piracetam in the treatment of post-concussional syndrome. A double-blind study». European Neurology17 (1): 50–55. 1978. doi:10.1159/000114922. PMID342247.
Giurgea, Corneliu E. (January 1982). «The nootropic concept and its prospective implications». Drug Development Research2 (5): 441–446. doi:10.1002/ddr.430020505. ISSN1098-2299.
«Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat». General Pharmacology18 (2): 205–11. 1987. doi:10.1016/0306-3623(87)90252-7. PMID3569848.
«Effect of the acquisition-enhancing drug piracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine». Biochemical Pharmacology25 (20): 2241–4. October 1976. doi:10.1016/0006-2952(76)90004-6. PMID985556.
«Rapid determination of piracetam in human plasma and cerebrospinal fluid by micellar electrokinetic chromatography with sample direct injection». J Chromatogr A1120 (1-2): 27–34. July 2006. doi:10.1016/j.chroma.2005.11.071. PMID16343512.
«A novel CaV2.2 channel inhibition by piracetam in peripheral and central neurons». Exp Biol Med (Maywood)237 (10): 1209–18. October 2012. doi:10.1258/ebm.2012.012128. PMID23045722.
Flicker, L; Grimley Evans, G (2001). «Piracetam for dementia or cognitive impairment.». The Cochrane Database of Systematic Reviews (2): CD001011. doi:10.1002/14651858.CD001011. PMID11405971.
«Pharmacotherapy for Vascular Cognitive Impairment». CNS Drugs31 (9): 759–776. September 2017. doi:10.1007/s40263-017-0459-3. PMID28786085. «Other medications have been considered or tried for the treatment of VCI or VaD. These include [...] piracetam. There is no convincing evidence about the efficacy of these medications in the treatment of VCI.».
«Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders». Drugs70 (3): 287–312. February 2010. doi:10.2165/11319230-000000000-00000. PMID20166767.
«Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials». CNS Drugs30 (7): 575–87. July 2016. doi:10.1007/s40263-016-0348-1. PMID27236454.
«Effects of Central Nervous System Drugs on Recovery After Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials». Clinical Drug Investigation37 (10): 901–928. October 2017. doi:10.1007/s40261-017-0558-4. PMID28756557.
«Piracetam in the treatment of post-concussional syndrome. A double-blind study». European Neurology17 (1): 50–55. 1978. doi:10.1159/000114922. PMID342247.
«Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat». General Pharmacology18 (2): 205–11. 1987. doi:10.1016/0306-3623(87)90252-7. PMID3569848.
«Effect of the acquisition-enhancing drug piracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine». Biochemical Pharmacology25 (20): 2241–4. October 1976. doi:10.1016/0006-2952(76)90004-6. PMID985556.
«Piracetam: physiological disposition and mechanism of action». Advances in Neurology43: 675–85. 1986. PMID3946121.
«Rapid determination of piracetam in human plasma and cerebrospinal fluid by micellar electrokinetic chromatography with sample direct injection». J Chromatogr A1120 (1-2): 27–34. July 2006. doi:10.1016/j.chroma.2005.11.071. PMID16343512.
«A novel CaV2.2 channel inhibition by piracetam in peripheral and central neurons». Exp Biol Med (Maywood)237 (10): 1209–18. October 2012. doi:10.1258/ebm.2012.012128. PMID23045722.
Giurgea, Corneliu E. (January 1982). «The nootropic concept and its prospective implications». Drug Development Research2 (5): 441–446. doi:10.1002/ddr.430020505. ISSN1098-2299.